Galenica acquires Medifilm Ltd., expanding its logistic offering with individualised supply of medication to patients in care homes
Thursday, 11 July 2013, ↓ directly to download
Through its pharmaceutical wholesaler Galexis, Galenica is acquiring Medifilm Ltd., a leading company in the field of blister packaging for medicines. With the specific services provided by Medifilm Ltd., Galexis will expand its offering to all pharmacies who prepare medicines for pa-tients on an individual basis on behalf of care homes.
Medifilm Ltd. will be positioned within the Logistics business sector of the Galenica Group and will continue to operate as an autonomous company under its existing management.
Medifilm Ltd. specialises in blister packaging medicines and nutritional supplements on behalf of pharmacies, according to the specific treatment plans for chronically ill and long-term patients; the brand name Medifilm® refers to the type of packaging used to do this. Tablets and capsules that must be taken regularly are prepared by machine in accordance with regulatory requirements on behalf of the customer, and are packed in sachets, each marked with the patient’s name, a description of the medication and the time at which it must be taken. This ensures that the process of administering medicines in the care home is efficient, thereby increasing the quality of care and drug safety for patients.
Medifilm Ltd. was established in 2007 and is now a contract manufacturer certified by Swissmedic and the market leader in blister packaging of medicines in Switzerland. The company is based in Oensingen in the canton of Solothurn and employs 25 members of staff. It supplies pharmacies that work together with care homes, helping to assure the provision of pharmaceutical care (medicines) to patients.
The aim is to further expand the offering for this growing market, taking into account the demand for high quality combined with industrial needs. In future, Medifilm Ltd. will benefit from the Galenica Group’s pharmaceutical and industrial expertise, allowing them the opportunity to implement expansion measures in order to meet growing demand across Switzerland.
By integrating Medifilm Ltd. in the Logistics business sector, Galexis will expand its range of services for all customers that prepare medicines for patients on an individual basis on behalf of care homes. The business will continue to operate as an autonomous company within the Galenica Group under its current management and with its existing team. This will ensure that Medifilm Ltd. can continue to of-fer its services to all interested market players in future.
The parties have agreed not to disclose the conditions of the transaction.
Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).
Thursday, 28 November 2013
Tuesday, 13 August 2013
Friday, 26 July 2013
Tuesday, 23 July 2013
Wednesday, 10 July 2013
Head of Corporate Communications